Neuromodulation for Treatment Resistant Depression: State of the Art and Recommendations for Clinical and Scientific Conduct
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Research of Deep Brain Stimulation as a putative treatment for resistant psychiatric disorders might very well lead to the most significant development in clinical psychiatry of the last 40 years-possibly offering a rise of hope for patients to whom medicine had hitherto little to offer. Furthermore, translational research on neuromodulation will allow us to glean something about the underlying cause of patient's illnesses before figuring out a treatment that addresses the source of the problem. Major depression offers perhaps the best example of the rapid progress being made in understanding the biology of mental illness. Studies on the underlying neurobiology of major depression have typically focused on the description of biological differences between patients and healthy subjects such as alterations of monoaminergic or endocrine systems. Psychotropic drugs work by altering neurochemistry to a large extent in widespread regions of the brain, many of which may be unrelated to depression. We believe that more focused, targeted treatment approaches that modulate specific networks in the brain will prove a more effective approach to help treatment-resistant patients. In other words, whereas existing depression treatments approach this disease as a general brain dysfunction, a more complete and appropriate treatment will arise from thinking of depression as a dysfunction of specific brain networks that mediate mood and reward signals (Berton and Nestler, Nat Rev Neurosci 7 (2):137-151, 2006; Krishnan and Nestler, Nature 455(7215):894-902, 2008). A better understanding of defined dysfunctions in these networks will invariably lead to a better understanding of patients afflicted with depression and perhaps contribute to a de-stigmatization of psychiatric patients and the medical specialty treating them.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Treatments with enhanced spatial specificity such as deep brain stimulation (DBS) or transcranial magnetic stimulation (TMS), aimed to restore region-specific hypoactivity, show great promise in alleviating treatment-resistant depression in even the most severe cases (2–10).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [6]
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · cited 2×
“vagus nerve stimulation, magnetic seizure therapy), a third of patients suffering from depression can be classified as treatment-resistant (Rush et al. 2006) with little hope of recovery, highly stigmatized and poor quality of life.”
BackgroundDeep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059 · cited 2×
“Immediate clinical effects after onset of stimulation include more spontaneous engagement in conversation, positive change in mood, increased alertness, relaxation, increased motivation, higher activity level and a sense of calmness (Bewernick et al. 2010; Holtzheimer et al. 2012; Mayberg et al. 2005).”
BackgroundThe molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889
New approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · cited 1×
“The nucleus accumbens (NAcc) is another structure that has been identified as a key center of the depression network (Berton and Nestler 2006).”
BackgroundLimbic-cortical dysregulation: a proposed model of depression
(1997) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.9.3.471 · Cited by 1,585 · cited 1×
“Psychotropic drugs work by altering neurochemistry to a large extent in widespread regions of the brain, many of which may be unrelated to depression.”
BackgroundOptical Deconstruction of Parkinsonian Neural Circuitry
Gradinaru, V., Mogri, M., Thompson, K. R., Henderson, J. M., & Deisseroth, K. (2009) · Science · doi:10.1126/science.1167093 · Cited by 1,526 · cited 2×
“fiber tracts are a plausible mechanism of action in DBS (Gradinaru et al. 2009).”
BackgroundNeurostimulation for Parkinson's Disease with Early Motor Complications
Schuepbach, W. M. M., Rau, J., Knudsen, K., Volkmann, J., Krack, P., Timmermann, L., Hälbig, T. D., Hesekamp, H., Navarro, S. M., Meier, N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205158 · Cited by 1,430
Deep Brain Stimulation to Reward Circuitry Alleviates Anhedonia in Refractory Major Depression
Schlaepfer, T. E., Cohen, M. X., Frick, C., Kosel, M., Brodesser, D., Axmacher, N., Joe, A. Y., Kreft, M., Lenartz, D., & Sturm, V. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301408 · Cited by 1,027 · cited 5×
“…assessments of therapeutic effects have to be conducted; despite the fact that blinding in the sham condition is not easy to maintain since patients often do not tolerate off phases leading to massive worsening of symptoms with increased risk for suicidal ideation (Schlaepfer et al. 2008).”
BackgroundInfluentialSelf-citationSubcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression
Lozano, A. M., Mayberg, H. S., Giacobbe, P., Hamani, C., Craddock, R. C., & Kennedy, S. H. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.034 · Cited by 1,024 · cited 5×
“Another study did not find a relationship between electrode location and clinical effect (Lozano et al. 2008).”
BackgroundInfluentialDeep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression
Malone, D. A., Dougherty, D. D., Rezai, A. R., Carpenter, L. L., Friehs, G. M., Eskandar, E. N., Rauch, S. L., Rasmussen, S. A., Machado, A. G., Kubu, C. S., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.029 · Cited by 897
Cited by
Francis, T. C., Chandra, R., Friend, D. M., Finkel, E., Dayrit, G., Miranda, J., Brooks, J. M., Iñiguez, S. D., O’Donnell, P., Kravitz, A., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.021 · Cited by 379
“sion receiving HFS DBS display larger improvements in depression symptoms after repeated stimulation as compared with acute stimulation (15,17,18).”
Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression
Francis, T. C., & Lobo, M. K. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.09.007 · Cited by 230
The neuroscience of depression: Implications for assessment and intervention
Singh, M. K., & Gotlib, I. H. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.08.008 · Cited by 83
“In contrast to medications that putatively work by altering neurochemistry throughout the brain, neuromodulation offers a more targeted approach to treatment that modulates specific networks in the brain (Schlaepfer & Bewernick, 2014).”
Gálvez, J. F., Keser, Z., Mwangi, B., Ghouse, A. A., Fenoy, A. J., Schulz, P. E., Sanches, M., Quevedo, J., Selvaraj, S., Gajwani, P., et al. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.12.003 · Cited by 56
Lefebvre, J., Frӧhlich, F., & Hutt, A. (2017) · eLife · doi:10.7554/elife.32054 · Cited by 55
Metadata
- Authors
- Schlaepfer, T. E., & Bewernick, B. H.
- Affiliations
- University Hospital Bonn (DE)
- Corresponding author
- Schlaepfer, Thomas E.
- Venue
- Brain Topography
- Published
- 2013-09-27
- Volume
- 27
- Issue
- 1
- Pages
- 12-19
- ISSN
- 0896-0267 (ISSN-L)
- 1573-6792
- OpenAlex
- W2150373585
- Cited by
- 17
- References
- 55
- Citations by year
- 2026: 2 · 2020: 1 · 2019: 1 · 2017: 2 · 2016: 3 · 2015: 4 · 2014: 3 · 2013: 1
- FWCI
- 0.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Brain Topography (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Keywords
- treatment-resistant depression, deep brain stimulation, neuromodulation, major depressive disorder, neurobiology of depression, brain networks, translational research, clinical guidelines
- MeSH terms
- Gyrus Cinguli, Humans, Medial Forebrain Bundle, Nucleus Accumbens, Internal Capsule, Deep Brain Stimulation, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuromodulation for Treatment Resistant Depression: State of the Art and Recommendations for Clinical and Scientific Conduct. https://app.cochat.ai/papers/10.1007/s10548-013-0315-9
- The paper
- Schlaepfer, T. E., & Bewernick, B. H. (2014). Neuromodulation for Treatment Resistant Depression: State of the Art and Recommendations for Clinical and Scientific Conduct. Brain Topography. https://doi.org/10.1007/s10548-013-0315-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.